世界のがんゲノム検査市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Cancer Genomic Testing Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-3954
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、105ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、がんゲノム検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（乳がんゲノム検査、肺がんゲノム検査、血液がんゲノム検査、肝臓がんゲノム検査、胃がんゲノム検査、その他）、用途別市場規模（病院、診療所、診断研究所、学術研究所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・がんゲノム検査の市場動向
・企業の競争状況、市場シェア
・がんゲノム検査の種類別市場規模と予測2016-2027（乳がんゲノム検査、肺がんゲノム検査、血液がんゲノム検査、肝臓がんゲノム検査、胃がんゲノム検査、その他）
・がんゲノム検査の用途別市場規模と予測2016-2027（病院、診療所、診断研究所、学術研究所、その他）
・がんゲノム検査の北米市場規模2016-2027（アメリカ、カナダ）
・がんゲノム検査の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・がんゲノム検査のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・がんゲノム検査の中南米市場規模2016-2027（メキシコ、ブラジル）
・がんゲノム検査の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Myriad Genetics、Centogene AG、Color Genomics、Quest Diagnostics、23andMe Inc.、Gene By Gene Ltd.、LabCorp、Positive Bioscience、Bio-Rad Laboratories、Illumina, Inc.、Agilent Technologies、Thermo Fisher Scientific）
・結論

Market Analysis and Insights: Global Cancer Genomic Testing Market
The global Cancer Genomic Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cancer Genomic Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cancer Genomic Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cancer Genomic Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cancer Genomic Testing market.

Global Cancer Genomic Testing Scope and Market Size
Cancer Genomic Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Genomic Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Breast Cancer Genomic Testing
Lung Cancer Genomic Testing
Blood Cancer Genomic Testing
Liver Cancer Genomic Testing
Stomach Cancer Genomic Testing
Others

Segment by Application
Hospitals
Clinics
Diagnostic Laboratories
Academic and Research Institutes
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Myriad Genetics
Centogene AG
Color Genomics
Quest Diagnostics
23andMe Inc.
Gene By Gene Ltd.
LabCorp
Positive Bioscience
Bio-Rad Laboratories
Illumina, Inc.
Agilent Technologies
Thermo Fisher Scientific

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Genomic Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Breast Cancer Genomic Testing
1.2.3 Lung Cancer Genomic Testing
1.2.4 Blood Cancer Genomic Testing
1.2.5 Liver Cancer Genomic Testing
1.2.6 Stomach Cancer Genomic Testing
1.2.7 Others
1.3 Market by Application
1.3.1 Global Cancer Genomic Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Diagnostic Laboratories
1.3.5 Academic and Research Institutes
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Cancer Genomic Testing Market Perspective (2016-2027)
2.2 Cancer Genomic Testing Growth Trends by Regions
2.2.1 Cancer Genomic Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cancer Genomic Testing Historic Market Share by Regions (2016-2021)
2.2.3 Cancer Genomic Testing Forecasted Market Size by Regions (2022-2027)
2.3 Cancer Genomic Testing Industry Dynamic
2.3.1 Cancer Genomic Testing Market Trends
2.3.2 Cancer Genomic Testing Market Drivers
2.3.3 Cancer Genomic Testing Market Challenges
2.3.4 Cancer Genomic Testing Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Cancer Genomic Testing Players by Revenue
3.1.1 Global Top Cancer Genomic Testing Players by Revenue (2016-2021)
3.1.2 Global Cancer Genomic Testing Revenue Market Share by Players (2016-2021)
3.2 Global Cancer Genomic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cancer Genomic Testing Revenue
3.4 Global Cancer Genomic Testing Market Concentration Ratio
3.4.1 Global Cancer Genomic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Genomic Testing Revenue in 2020
3.5 Cancer Genomic Testing Key Players Head office and Area Served
3.6 Key Players Cancer Genomic Testing Product Solution and Service
3.7 Date of Enter into Cancer Genomic Testing Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Cancer Genomic Testing Breakdown Data by Type
4.1 Global Cancer Genomic Testing Historic Market Size by Type (2016-2021)
4.2 Global Cancer Genomic Testing Forecasted Market Size by Type (2022-2027)

5 Cancer Genomic Testing Breakdown Data by Application
5.1 Global Cancer Genomic Testing Historic Market Size by Application (2016-2021)
5.2 Global Cancer Genomic Testing Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Cancer Genomic Testing Market Size (2016-2027)
6.2 North America Cancer Genomic Testing Market Size by Type
6.2.1 North America Cancer Genomic Testing Market Size by Type (2016-2021)
6.2.2 North America Cancer Genomic Testing Market Size by Type (2022-2027)
6.2.3 North America Cancer Genomic Testing Market Size by Type (2016-2027)
6.3 North America Cancer Genomic Testing Market Size by Application
6.3.1 North America Cancer Genomic Testing Market Size by Application (2016-2021)
6.3.2 North America Cancer Genomic Testing Market Size by Application (2022-2027)
6.3.3 North America Cancer Genomic Testing Market Size by Application (2016-2027)
6.4 North America Cancer Genomic Testing Market Size by Country
6.4.1 North America Cancer Genomic Testing Market Size by Country (2016-2021)
6.4.2 North America Cancer Genomic Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Cancer Genomic Testing Market Size (2016-2027)
7.2 Europe Cancer Genomic Testing Market Size by Type
7.2.1 Europe Cancer Genomic Testing Market Size by Type (2016-2021)
7.2.2 Europe Cancer Genomic Testing Market Size by Type (2022-2027)
7.2.3 Europe Cancer Genomic Testing Market Size by Type (2016-2027)
7.3 Europe Cancer Genomic Testing Market Size by Application
7.3.1 Europe Cancer Genomic Testing Market Size by Application (2016-2021)
7.3.2 Europe Cancer Genomic Testing Market Size by Application (2022-2027)
7.3.3 Europe Cancer Genomic Testing Market Size by Application (2016-2027)
7.4 Europe Cancer Genomic Testing Market Size by Country
7.4.1 Europe Cancer Genomic Testing Market Size by Country (2016-2021)
7.4.2 Europe Cancer Genomic Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Cancer Genomic Testing Market Size (2016-2027)
8.2 Asia-Pacific Cancer Genomic Testing Market Size by Type
8.2.1 Asia-Pacific Cancer Genomic Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cancer Genomic Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cancer Genomic Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific Cancer Genomic Testing Market Size by Application
8.3.1 Asia-Pacific Cancer Genomic Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cancer Genomic Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cancer Genomic Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific Cancer Genomic Testing Market Size by Region
8.4.1 Asia-Pacific Cancer Genomic Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cancer Genomic Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Cancer Genomic Testing Market Size (2016-2027)
9.2 Latin America Cancer Genomic Testing Market Size by Type
9.2.1 Latin America Cancer Genomic Testing Market Size by Type (2016-2021)
9.2.2 Latin America Cancer Genomic Testing Market Size by Type (2022-2027)
9.2.3 Latin America Cancer Genomic Testing Market Size by Type (2016-2027)
9.3 Latin America Cancer Genomic Testing Market Size by Application
9.3.1 Latin America Cancer Genomic Testing Market Size by Application (2016-2021)
9.3.2 Latin America Cancer Genomic Testing Market Size by Application (2022-2027)
9.3.3 Latin America Cancer Genomic Testing Market Size by Application (2016-2027)
9.4 Latin America Cancer Genomic Testing Market Size by Country
9.4.1 Latin America Cancer Genomic Testing Market Size by Country (2016-2021)
9.4.2 Latin America Cancer Genomic Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Cancer Genomic Testing Market Size (2016-2027)
10.2 Middle East & Africa Cancer Genomic Testing Market Size by Type
10.2.1 Middle East & Africa Cancer Genomic Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cancer Genomic Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cancer Genomic Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa Cancer Genomic Testing Market Size by Application
10.3.1 Middle East & Africa Cancer Genomic Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cancer Genomic Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cancer Genomic Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa Cancer Genomic Testing Market Size by Country
10.4.1 Middle East & Africa Cancer Genomic Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cancer Genomic Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Myriad Genetics
11.1.1 Myriad Genetics Company Details
11.1.2 Myriad Genetics Business Overview
11.1.3 Myriad Genetics Cancer Genomic Testing Introduction
11.1.4 Myriad Genetics Revenue in Cancer Genomic Testing Business (2016-2021)
11.1.5 Myriad Genetics Recent Development
11.2 Centogene AG
11.2.1 Centogene AG Company Details
11.2.2 Centogene AG Business Overview
11.2.3 Centogene AG Cancer Genomic Testing Introduction
11.2.4 Centogene AG Revenue in Cancer Genomic Testing Business (2016-2021)
11.2.5 Centogene AG Recent Development
11.3 Color Genomics
11.3.1 Color Genomics Company Details
11.3.2 Color Genomics Business Overview
11.3.3 Color Genomics Cancer Genomic Testing Introduction
11.3.4 Color Genomics Revenue in Cancer Genomic Testing Business (2016-2021)
11.3.5 Color Genomics Recent Development
11.4 Quest Diagnostics
11.4.1 Quest Diagnostics Company Details
11.4.2 Quest Diagnostics Business Overview
11.4.3 Quest Diagnostics Cancer Genomic Testing Introduction
11.4.4 Quest Diagnostics Revenue in Cancer Genomic Testing Business (2016-2021)
11.4.5 Quest Diagnostics Recent Development
11.5 23andMe Inc.
11.5.1 23andMe Inc. Company Details
11.5.2 23andMe Inc. Business Overview
11.5.3 23andMe Inc. Cancer Genomic Testing Introduction
11.5.4 23andMe Inc. Revenue in Cancer Genomic Testing Business (2016-2021)
11.5.5 23andMe Inc. Recent Development
11.6 Gene By Gene Ltd.
11.6.1 Gene By Gene Ltd. Company Details
11.6.2 Gene By Gene Ltd. Business Overview
11.6.3 Gene By Gene Ltd. Cancer Genomic Testing Introduction
11.6.4 Gene By Gene Ltd. Revenue in Cancer Genomic Testing Business (2016-2021)
11.6.5 Gene By Gene Ltd. Recent Development
11.7 LabCorp
11.7.1 LabCorp Company Details
11.7.2 LabCorp Business Overview
11.7.3 LabCorp Cancer Genomic Testing Introduction
11.7.4 LabCorp Revenue in Cancer Genomic Testing Business (2016-2021)
11.7.5 LabCorp Recent Development
11.8 Positive Bioscience
11.8.1 Positive Bioscience Company Details
11.8.2 Positive Bioscience Business Overview
11.8.3 Positive Bioscience Cancer Genomic Testing Introduction
11.8.4 Positive Bioscience Revenue in Cancer Genomic Testing Business (2016-2021)
11.8.5 Positive Bioscience Recent Development
11.9 Bio-Rad Laboratories
11.9.1 Bio-Rad Laboratories Company Details
11.9.2 Bio-Rad Laboratories Business Overview
11.9.3 Bio-Rad Laboratories Cancer Genomic Testing Introduction
11.9.4 Bio-Rad Laboratories Revenue in Cancer Genomic Testing Business (2016-2021)
11.9.5 Bio-Rad Laboratories Recent Development
11.10 Illumina, Inc.
11.10.1 Illumina, Inc. Company Details
11.10.2 Illumina, Inc. Business Overview
11.10.3 Illumina, Inc. Cancer Genomic Testing Introduction
11.10.4 Illumina, Inc. Revenue in Cancer Genomic Testing Business (2016-2021)
11.10.5 Illumina, Inc. Recent Development
11.11 Agilent Technologies
11.11.1 Agilent Technologies Company Details
11.11.2 Agilent Technologies Business Overview
11.11.3 Agilent Technologies Cancer Genomic Testing Introduction
11.11.4 Agilent Technologies Revenue in Cancer Genomic Testing Business (2016-2021)
11.11.5 Agilent Technologies Recent Development
11.12 Thermo Fisher Scientific
11.12.1 Thermo Fisher Scientific Company Details
11.12.2 Thermo Fisher Scientific Business Overview
11.12.3 Thermo Fisher Scientific Cancer Genomic Testing Introduction
11.12.4 Thermo Fisher Scientific Revenue in Cancer Genomic Testing Business (2016-2021)
11.12.5 Thermo Fisher Scientific Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Cancer Genomic Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Breast Cancer Genomic Testing
Table 3. Key Players of Lung Cancer Genomic Testing
Table 4. Key Players of Blood Cancer Genomic Testing
Table 5. Key Players of Liver Cancer Genomic Testing
Table 6. Key Players of Stomach Cancer Genomic Testing
Table 7. Key Players of Others
Table 8. Global Cancer Genomic Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Cancer Genomic Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Cancer Genomic Testing Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Cancer Genomic Testing Market Share by Regions (2016-2021)
Table 12. Global Cancer Genomic Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Cancer Genomic Testing Market Share by Regions (2022-2027)
Table 14. Cancer Genomic Testing Market Trends
Table 15. Cancer Genomic Testing Market Drivers
Table 16. Cancer Genomic Testing Market Challenges
Table 17. Cancer Genomic Testing Market Restraints
Table 18. Global Cancer Genomic Testing Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Cancer Genomic Testing Market Share by Players (2016-2021)
Table 20. Global Top Cancer Genomic Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Genomic Testing as of 2020)
Table 21. Ranking of Global Top Cancer Genomic Testing Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Cancer Genomic Testing Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Cancer Genomic Testing Product Solution and Service
Table 25. Date of Enter into Cancer Genomic Testing Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Cancer Genomic Testing Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Cancer Genomic Testing Revenue Market Share by Type (2016-2021)
Table 29. Global Cancer Genomic Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Cancer Genomic Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Cancer Genomic Testing Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Cancer Genomic Testing Revenue Market Share by Application (2016-2021)
Table 33. Global Cancer Genomic Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Cancer Genomic Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Cancer Genomic Testing Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Cancer Genomic Testing Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Cancer Genomic Testing Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Cancer Genomic Testing Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Cancer Genomic Testing Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Cancer Genomic Testing Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Cancer Genomic Testing Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Cancer Genomic Testing Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Cancer Genomic Testing Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Cancer Genomic Testing Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Cancer Genomic Testing Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Cancer Genomic Testing Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Cancer Genomic Testing Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Cancer Genomic Testing Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Cancer Genomic Testing Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Cancer Genomic Testing Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Cancer Genomic Testing Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Cancer Genomic Testing Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Cancer Genomic Testing Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Cancer Genomic Testing Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Cancer Genomic Testing Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Cancer Genomic Testing Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Cancer Genomic Testing Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Cancer Genomic Testing Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Cancer Genomic Testing Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Cancer Genomic Testing Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Cancer Genomic Testing Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Cancer Genomic Testing Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Cancer Genomic Testing Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Cancer Genomic Testing Market Size by Country (2022-2027) & (US$ Million)
Table 65. Myriad Genetics Company Details
Table 66. Myriad Genetics Business Overview
Table 67. Myriad Genetics Cancer Genomic Testing Product
Table 68. Myriad Genetics Revenue in Cancer Genomic Testing Business (2016-2021) & (US$ Million)
Table 69. Myriad Genetics Recent Development
Table 70. Centogene AG Company Details
Table 71. Centogene AG Business Overview
Table 72. Centogene AG Cancer Genomic Testing Product
Table 73. Centogene AG Revenue in Cancer Genomic Testing Business (2016-2021) & (US$ Million)
Table 74. Centogene AG Recent Development
Table 75. Color Genomics Company Details
Table 76. Color Genomics Business Overview
Table 77. Color Genomics Cancer Genomic Testing Product
Table 78. Color Genomics Revenue in Cancer Genomic Testing Business (2016-2021) & (US$ Million)
Table 79. Color Genomics Recent Development
Table 80. Quest Diagnostics Company Details
Table 81. Quest Diagnostics Business Overview
Table 82. Quest Diagnostics Cancer Genomic Testing Product
Table 83. Quest Diagnostics Revenue in Cancer Genomic Testing Business (2016-2021) & (US$ Million)
Table 84. Quest Diagnostics Recent Development
Table 85. 23andMe Inc. Company Details
Table 86. 23andMe Inc. Business Overview
Table 87. 23andMe Inc. Cancer Genomic Testing Product
Table 88. 23andMe Inc. Revenue in Cancer Genomic Testing Business (2016-2021) & (US$ Million)
Table 89. 23andMe Inc. Recent Development
Table 90. Gene By Gene Ltd. Company Details
Table 91. Gene By Gene Ltd. Business Overview
Table 92. Gene By Gene Ltd. Cancer Genomic Testing Product
Table 93. Gene By Gene Ltd. Revenue in Cancer Genomic Testing Business (2016-2021) & (US$ Million)
Table 94. Gene By Gene Ltd. Recent Development
Table 95. LabCorp Company Details
Table 96. LabCorp Business Overview
Table 97. LabCorp Cancer Genomic Testing Product
Table 98. LabCorp Revenue in Cancer Genomic Testing Business (2016-2021) & (US$ Million)
Table 99. LabCorp Recent Development
Table 100. Positive Bioscience Company Details
Table 101. Positive Bioscience Business Overview
Table 102. Positive Bioscience Revenue in Cancer Genomic Testing Business (2016-2021) & (US$ Million)
Table 103. Positive Bioscience Recent Development
Table 104. Bio-Rad Laboratories Company Details
Table 105. Bio-Rad Laboratories Business Overview
Table 106. Bio-Rad Laboratories Cancer Genomic Testing Product
Table 107. Bio-Rad Laboratories Revenue in Cancer Genomic Testing Business (2016-2021) & (US$ Million)
Table 108. Bio-Rad Laboratories Recent Development
Table 109. Illumina, Inc. Company Details
Table 110. Illumina, Inc. Business Overview
Table 111. Illumina, Inc. Cancer Genomic Testing Product
Table 112. Illumina, Inc. Revenue in Cancer Genomic Testing Business (2016-2021) & (US$ Million)
Table 113. Illumina, Inc. Recent Development
Table 114. Agilent Technologies Company Details
Table 115. Agilent Technologies Business Overview
Table 116. Agilent Technologies Cancer Genomic Testing Product
Table 117. Agilent Technologies Revenue in Cancer Genomic Testing Business (2016-2021) & (US$ Million)
Table 118. Agilent Technologies Recent Development
Table 119. Thermo Fisher Scientific Company Details
Table 120. Thermo Fisher Scientific Business Overview
Table 121. Thermo Fisher Scientific Cancer Genomic Testing Product
Table 122. Thermo Fisher Scientific Revenue in Cancer Genomic Testing Business (2016-2021) & (US$ Million)
Table 123. Thermo Fisher Scientific Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Genomic Testing Market Share by Type: 2020 VS 2027
Figure 2. Breast Cancer Genomic Testing Features
Figure 3. Lung Cancer Genomic Testing Features
Figure 4. Blood Cancer Genomic Testing Features
Figure 5. Liver Cancer Genomic Testing Features
Figure 6. Stomach Cancer Genomic Testing Features
Figure 7. Others Features
Figure 8. Global Cancer Genomic Testing Market Share by Application: 2020 VS 2027
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Diagnostic Laboratories Case Studies
Figure 12. Academic and Research Institutes Case Studies
Figure 13. Others Case Studies
Figure 14. Cancer Genomic Testing Report Years Considered
Figure 15. Global Cancer Genomic Testing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global Cancer Genomic Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Cancer Genomic Testing Market Share by Regions: 2020 VS 2027
Figure 18. Global Cancer Genomic Testing Market Share by Regions (2022-2027)
Figure 19. Global Cancer Genomic Testing Market Share by Players in 2020
Figure 20. Global Top Cancer Genomic Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Genomic Testing as of 2020
Figure 21. The Top 10 and 5 Players Market Share by Cancer Genomic Testing Revenue in 2020
Figure 22. Global Cancer Genomic Testing Revenue Market Share by Type (2016-2021)
Figure 23. Global Cancer Genomic Testing Revenue Market Share by Type (2022-2027)
Figure 24. North America Cancer Genomic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America Cancer Genomic Testing Market Share by Type (2016-2027)
Figure 26. North America Cancer Genomic Testing Market Share by Application (2016-2027)
Figure 27. North America Cancer Genomic Testing Market Share by Country (2016-2027)
Figure 28. United States Cancer Genomic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada Cancer Genomic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Cancer Genomic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Cancer Genomic Testing Market Share by Type (2016-2027)
Figure 32. Europe Cancer Genomic Testing Market Share by Application (2016-2027)
Figure 33. Europe Cancer Genomic Testing Market Share by Country (2016-2027)
Figure 34. Germany Cancer Genomic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France Cancer Genomic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. Cancer Genomic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy Cancer Genomic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia Cancer Genomic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic Cancer Genomic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Cancer Genomic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Cancer Genomic Testing Market Share by Type (2016-2027)
Figure 42. Asia-Pacific Cancer Genomic Testing Market Share by Application (2016-2027)
Figure 43. Asia-Pacific Cancer Genomic Testing Market Share by Region (2016-2027)
Figure 44. China Cancer Genomic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan Cancer Genomic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea Cancer Genomic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia Cancer Genomic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India Cancer Genomic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia Cancer Genomic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Cancer Genomic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Cancer Genomic Testing Market Share by Type (2016-2027)
Figure 52. Latin America Cancer Genomic Testing Market Share by Application (2016-2027)
Figure 53. Latin America Cancer Genomic Testing Market Share by Country (2016-2027)
Figure 54. Mexico Cancer Genomic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil Cancer Genomic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Cancer Genomic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Cancer Genomic Testing Market Share by Type (2016-2027)
Figure 58. Middle East & Africa Cancer Genomic Testing Market Share by Application (2016-2027)
Figure 59. Middle East & Africa Cancer Genomic Testing Market Share by Country (2016-2027)
Figure 60. Turkey Cancer Genomic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia Cancer Genomic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE Cancer Genomic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Myriad Genetics Revenue Growth Rate in Cancer Genomic Testing Business (2016-2021)
Figure 64. Centogene AG Revenue Growth Rate in Cancer Genomic Testing Business (2016-2021)
Figure 65. Color Genomics Revenue Growth Rate in Cancer Genomic Testing Business (2016-2021)
Figure 66. Quest Diagnostics Revenue Growth Rate in Cancer Genomic Testing Business (2016-2021)
Figure 67. 23andMe Inc. Revenue Growth Rate in Cancer Genomic Testing Business (2016-2021)
Figure 68. Gene By Gene Ltd. Revenue Growth Rate in Cancer Genomic Testing Business (2016-2021)
Figure 69. LabCorp Revenue Growth Rate in Cancer Genomic Testing Business (2016-2021)
Figure 70. Positive Bioscience Revenue Growth Rate in Cancer Genomic Testing Business (2016-2021)
Figure 71. Bio-Rad Laboratories Revenue Growth Rate in Cancer Genomic Testing Business (2016-2021)
Figure 72. Illumina, Inc. Revenue Growth Rate in Cancer Genomic Testing Business (2016-2021)
Figure 73. Agilent Technologies Revenue Growth Rate in Cancer Genomic Testing Business (2016-2021)
Figure 74. Thermo Fisher Scientific Revenue Growth Rate in Cancer Genomic Testing Business (2016-2021)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed

以下、関連資料のご紹介

世界のリンパ癌検査市場規模・現状・予測（2021年-2027年）

Global Lymph Cancer Testing Market Size, Status and Forecast 2021-2027
QFJ1-4447 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、リンパ癌検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（核医療検査、血液検査、生検、その他）、用途別市場規模（病院、クリニック、がんセンター）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日...

世界の乳がん検査市場規模・現状・予測（2021年-2027年）

Global Breast Cancer Testing Market Size, Status and Forecast 2021-2027
QFJ1-3940 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、乳がん検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（スクリーニング検査、診断検査、モニタリング検査）、用途別市場規模（非浸潤性乳がん、浸潤性乳がん）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の腫瘍血液検査市場規模・現状・予測（2021年-2027年）

Global Oncology Blood Testing Market Size, Status and Forecast 2021-2027
QFJ1-4605 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、腫瘍血液検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（肺がん、乳がん、結腸直腸がん、前立腺がん、胃がん、その）、用途別市場規模（病院、クリニック、外来手術センター）、主要地域別市場規模（北米、ア...

世界の小児遺伝子検査市場規模・現状・予測（2021年-2027年）

Global Pediatric Genetic Testing Market Size, Status and Forecast 2021-2027
QFJ1-4673 2021年6月 118Pages
QYResearch社発行の本調査レポートでは、小児遺伝子検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（キット、LDT検査、試薬）、用途別市場規模（学術研究、臨床診断、創薬、モニタリング・スクリーニング）、主要地域別市場規模（北米、アメリカ、...

世界の胃がん検査・治療・予防市場規模・現状・予測（2021年-2027年）

Global Gastric Cancer Testing, Treatment and Prevention Market Size, Status and Forecast 2021-2027
QFJ1-3461 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、胃がん検査・治療・予防の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（検査、治療、予防）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イ...

世界のがん腫瘍プロファイリング市場規模・現状・予測（2021年-2027年）

Global Cancer Tumor Profiling Market Size, Status and Forecast 2021-2027
QFJ1-3960 2021年6月 120Pages
QYResearch社発行の本調査レポートでは、がん腫瘍プロファイリングの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（次世代シーケンシング（NGS）、ポリメラーゼ連鎖反応（PCR）、免疫組織化学（IHC）、インサイツハイブリダイゼーション（ISH...

世界の免疫組織化学（IHC）検査市場規模・現状・予測（2021年-2027年）

Global Immunohistochemistry (IHC) Testing Market Size, Status and Forecast 2021-2027
QFJ1-5207 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、免疫組織化学（IHC）検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（従来式直接法、新直接法、酵素架橋法、PAP法）、用途別市場規模（病院、研究所、企業、その他）、主要地域別市場規模（北米、アメリ...

世界の予測診断市場規模・現状・予測（2021年-2027年）

Global Predictive Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-4748 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、予測診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（遺伝子検査、保因者特定、がん検査、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界のがん診断精密検査市場規模・現状・予測（2021年-2027年）

Global Precision Cancer Diagnostic Tests Market Size, Status and Forecast 2021-2027
QFJ1-5312 2021年6月 128Pages
QYResearch社発行の本調査レポートでは、がん診断精密検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（画像、分子、組織/細胞、腫瘍マーカーイムノアッセイ、POC結腸がん検査）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模...

世界の腫瘍バイオマーカー市場規模・現状・予測（2021年-2027年）

Global Oncology Biomarker Market Size, Status and Forecast 2021-2027
QFJ1-4604 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、腫瘍バイオマーカーの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（血液がん、固形腫瘍、その他）、用途別市場規模（診断、創薬・開発、予後、リスクアセスメント、その他）、主要地域別市場規模（北米、アメリカ...

世界のリンパ癌検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Lymph Cancer Testing Market The global Lymph Cancer Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report m…
世界の乳がん検査市場規模・現状・予測（2021年-2027年） Breast cancer is one of the most common malignant tumors in women, which poses a great threat to women's life and health.In recent years, as people pay more attention to women's health, the detection methods of their diseases have been greatly improved.Breast cancer tests include screening tests, di…
世界の腫瘍血液検査市場規模・現状・予測（2021年-2027年） Oncology blood testing is a revolutionary diagnostic technique to detect cancer in early stages. For early detection of cancer, liquid biopsies have become a popular diagnostic tool. Market Analysis and Insights: Global Oncology Blood Testing Market The global Oncology Blood Testing market size is p…
乳がん検査のグローバル市場：規模・現状・予測2019-2025 Breast cancer is one of the most common malignant tumors in women, which poses a great threat to women's life and health.In recent years, as people pay more attention to women's health, the detection methods of their diseases have been greatly improved.Breast cancer tests include screening tests, di…
乳がん検査のグローバル市場：規模・現状・予測2019-2025 Breast cancer is one of the most common malignant tumors in women, which poses a great threat to women's life and health.In recent years, as people pay more attention to women's health, the detection methods of their diseases have been greatly improved.Breast cancer tests include screening tests, di…